Back to Catalog

For Research Use Only. Not for use in diagnostic procedures.

Urinary TractFor Research Use Only

Urinary Tract Infection qPCR Reagents

Code: UTI-4-12  |  Category: Urinary Tract

Target List

Bacteria

23
  • Acinetobacter baumannii
  • Actinotignum schaalii
  • Aerococcus urinae
  • Bacteroides fragilis
  • Citrobacter spp. (freundii/braakii/koseri)
  • Enterobacter cloacae
  • Enterococcus faecalis
  • Enterococcus faecium
  • Escherichia coli
  • Klebsiella (Enterobacter) aerogenes
  • Klebsiella oxytoca
  • Klebsiella pneumoniae
  • Morganella morganii
  • Prevotella bivia
  • Proteus mirabilis
  • Proteus vulgaris
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Staphylococcus aureus
  • Staphylococcus haemolyticus
  • Staphylococcus saprophyticus
  • Streptococcus agalactiae (Group B)
  • Streptococcus pyogenes (Group A)

Fungus

7
  • Candida albicans
  • Candida auris
  • Candida glabrata
  • Candida parapsilosis
  • Candida tropicalis
  • Epidermophyton floccosum
  • Trichophyton rubrum

Antimicrobial Resistance Marker

15
  • Class A beta-lactamase resistance (blaSHV)
  • Class A beta-lactamase resistance (blaTEM)
  • Class A beta-lactamase resistance (CTX-M-Grp1)
  • Class B beta-lactamase resistance (blaNDM-1/blaNDM-4/blaNDM-5/blaNDM-7)
  • Class D beta-lactamase resistance (OXA-48/OXA-51)
  • Fluoroquinolone resistance (gyrA)
  • Fluoroquinolone resistance (qnrA/qnrB/qnrS)
  • Methicillin resistance (mecA)
  • Sulfonamide resistance (sul1)
  • Tetracycline resistance (tetB)
  • Tetracycline resistance (tetM)
  • Trimethoprim resistance (dfrA1)
  • Vancomycin resistance (vanA)
  • Vancomycin resistance (vanB)
  • Vancomycin resistance (vanM)

Specifications

Well Count12
Pathogen Targets30
AMR Targets15
Total Targets45
Samples / 384-Well Cycle30
Samples / 96-Well Cycle6

Controls Included

Positive Control
Exogenous Extraction Control (B. atrophaeus)
RNase P

Interested in this reagent kit?

Contact our team for technical specifications, custom configuration requests, or research collaboration inquiries.